Health Catalyst Inc
NASDAQ:HCAT
Intrinsic Value
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. [ Read More ]
The intrinsic value of one HCAT stock under the Base Case scenario is 10.38 USD. Compared to the current market price of 5.58 USD, Health Catalyst Inc is Undervalued by 46%.
Valuation Backtest
Health Catalyst Inc
Run backtest to discover the historical profit from buying and selling HCAT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Health Catalyst Inc
Current Assets | 393.4m |
Cash & Short-Term Investments | 317.7m |
Receivables | 60.3m |
Other Current Assets | 15.4m |
Non-Current Assets | 308.4m |
PP&E | 39.6m |
Intangibles | 264m |
Other Non-Current Assets | 4.7m |
Current Liabilities | 89m |
Accounts Payable | 6.6m |
Accrued Liabilities | 26.6m |
Other Current Liabilities | 55.8m |
Non-Current Liabilities | 245.9m |
Long-Term Debt | 228m |
Other Non-Current Liabilities | 17.8m |
Earnings Waterfall
Health Catalyst Inc
Revenue
|
295.9m
USD
|
Cost of Revenue
|
-161.1m
USD
|
Gross Profit
|
134.8m
USD
|
Operating Expenses
|
-221.8m
USD
|
Operating Income
|
-87m
USD
|
Other Expenses
|
-31.2m
USD
|
Net Income
|
-118.1m
USD
|
Free Cash Flow Analysis
Health Catalyst Inc
What is Free Cash Flow?
HCAT Profitability Score
Profitability Due Diligence
Health Catalyst Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Health Catalyst Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
HCAT Solvency Score
Solvency Due Diligence
Health Catalyst Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Health Catalyst Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for HCAT is 12.17 USD with a low forecast of 8.08 USD and a high forecast of 16.8 USD.
Ownership
HCAT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HCAT Price
Health Catalyst Inc
Average Annual Return | -16.91% |
Standard Deviation of Annual Returns | 41.54% |
Max Drawdown | -91% |
Market Capitalization | 325.3m USD |
Shares Outstanding | 58 563 000 |
Percentage of Shares Shorted | 2.95% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm operates in two segments: technology and professional services. The technology segment includes its data platform, analytics applications and support services. Its solution consists of a cloud-based data platform, analytics software and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data from its software systems, which enables a range of analytics. Its software analytics application is built on top of its data platform to provide foundational or domain-specific insights that improve customers clinical, financial and operational performance. Its support services consist of both analytics experts and domain experts.
Contact
IPO
Employees
Officers
The intrinsic value of one HCAT stock under the Base Case scenario is 10.38 USD.
Compared to the current market price of 5.58 USD, Health Catalyst Inc is Undervalued by 46%.